American Society for Clinical Pharmacology and Therapeutics Position Statement on Dietary Supplement Safety and Regulation*
2005; Wiley; Volume: 77; Issue: 3 Linguagem: Inglês
10.1016/j.clpt.2005.01.017
ISSN1532-6535
AutoresJason D. Morrow, Timi Edeki, Mohamed El Mouelhi, Raymond E. Galinsky, Rose Kovelesky, Robert J. Noveck, Charles Preuss,
Tópico(s)Pharmaceutical studies and practices
ResumoClinical Pharmacology & TherapeuticsVolume 77, Issue 3 p. 113-122 ASCPT Position Statement American Society for Clinical Pharmacology and Therapeutics Position Statement on Dietary Supplement Safety and Regulation Jason D. Morrow MD, Chair, Jason D. Morrow MD, Chair Vanderbilt University, Nashville Abbott Clinical Pharmacology, Waukegan Procter and Gamble Pharmaceuticals, Mason Purdue University, Indianapolis; Chiron Corporation, Emeryville MDS Pharma Services, New Orleans Palm Beach Atlantic University, West Palm BeachSearch for more papers by this authorTimi I. Edeki MD, PhD, Timi I. Edeki MD, PhD Vanderbilt University, Nashville Abbott Clinical Pharmacology, Waukegan Procter and Gamble Pharmaceuticals, Mason Purdue University, Indianapolis; Chiron Corporation, Emeryville MDS Pharma Services, New Orleans Palm Beach Atlantic University, West Palm BeachSearch for more papers by this authorMohamed El Mouelhi MD, PhD, Mohamed El Mouelhi MD, PhD Vanderbilt University, Nashville Abbott Clinical Pharmacology, Waukegan Procter and Gamble Pharmaceuticals, Mason Purdue University, Indianapolis; Chiron Corporation, Emeryville MDS Pharma Services, New Orleans Palm Beach Atlantic University, West Palm BeachSearch for more papers by this authorRaymond E. Galinsky PharmD, Raymond E. Galinsky PharmD Vanderbilt University, Nashville Abbott Clinical Pharmacology, Waukegan Procter and Gamble Pharmaceuticals, Mason Purdue University, Indianapolis; Chiron Corporation, Emeryville MDS Pharma Services, New Orleans Palm Beach Atlantic University, West Palm BeachSearch for more papers by this authorRose Kovelesky RPh, PhD, Rose Kovelesky RPh, PhD Vanderbilt University, Nashville Abbott Clinical Pharmacology, Waukegan Procter and Gamble Pharmaceuticals, Mason Purdue University, Indianapolis; Chiron Corporation, Emeryville MDS Pharma Services, New Orleans Palm Beach Atlantic University, West Palm BeachSearch for more papers by this authorRobert J. Noveck MD, PhD, Robert J. Noveck MD, PhD Vanderbilt University, Nashville Abbott Clinical Pharmacology, Waukegan Procter and Gamble Pharmaceuticals, Mason Purdue University, Indianapolis; Chiron Corporation, Emeryville MDS Pharma Services, New Orleans Palm Beach Atlantic University, West Palm BeachSearch for more papers by this authorCharles Preuss RPh, PhD, Charles Preuss RPh, PhD Vanderbilt University, Nashville Abbott Clinical Pharmacology, Waukegan Procter and Gamble Pharmaceuticals, Mason Purdue University, Indianapolis; Chiron Corporation, Emeryville MDS Pharma Services, New Orleans Palm Beach Atlantic University, West Palm BeachSearch for more papers by this authorAmerican Society for Clinical Pharmacology and Therapeutics Task Force on Dietary Supplements, Corresponding Author American Society for Clinical Pharmacology and Therapeutics Task Force on Dietary Supplements Michele Boisse, American Society for Clinical Pharmacology and Therapeutics, 528 N. Washington St, Alexandria, VA 22314. E-mail: [email protected]Search for more papers by this author Jason D. Morrow MD, Chair, Jason D. Morrow MD, Chair Vanderbilt University, Nashville Abbott Clinical Pharmacology, Waukegan Procter and Gamble Pharmaceuticals, Mason Purdue University, Indianapolis; Chiron Corporation, Emeryville MDS Pharma Services, New Orleans Palm Beach Atlantic University, West Palm BeachSearch for more papers by this authorTimi I. Edeki MD, PhD, Timi I. Edeki MD, PhD Vanderbilt University, Nashville Abbott Clinical Pharmacology, Waukegan Procter and Gamble Pharmaceuticals, Mason Purdue University, Indianapolis; Chiron Corporation, Emeryville MDS Pharma Services, New Orleans Palm Beach Atlantic University, West Palm BeachSearch for more papers by this authorMohamed El Mouelhi MD, PhD, Mohamed El Mouelhi MD, PhD Vanderbilt University, Nashville Abbott Clinical Pharmacology, Waukegan Procter and Gamble Pharmaceuticals, Mason Purdue University, Indianapolis; Chiron Corporation, Emeryville MDS Pharma Services, New Orleans Palm Beach Atlantic University, West Palm BeachSearch for more papers by this authorRaymond E. Galinsky PharmD, Raymond E. Galinsky PharmD Vanderbilt University, Nashville Abbott Clinical Pharmacology, Waukegan Procter and Gamble Pharmaceuticals, Mason Purdue University, Indianapolis; Chiron Corporation, Emeryville MDS Pharma Services, New Orleans Palm Beach Atlantic University, West Palm BeachSearch for more papers by this authorRose Kovelesky RPh, PhD, Rose Kovelesky RPh, PhD Vanderbilt University, Nashville Abbott Clinical Pharmacology, Waukegan Procter and Gamble Pharmaceuticals, Mason Purdue University, Indianapolis; Chiron Corporation, Emeryville MDS Pharma Services, New Orleans Palm Beach Atlantic University, West Palm BeachSearch for more papers by this authorRobert J. Noveck MD, PhD, Robert J. Noveck MD, PhD Vanderbilt University, Nashville Abbott Clinical Pharmacology, Waukegan Procter and Gamble Pharmaceuticals, Mason Purdue University, Indianapolis; Chiron Corporation, Emeryville MDS Pharma Services, New Orleans Palm Beach Atlantic University, West Palm BeachSearch for more papers by this authorCharles Preuss RPh, PhD, Charles Preuss RPh, PhD Vanderbilt University, Nashville Abbott Clinical Pharmacology, Waukegan Procter and Gamble Pharmaceuticals, Mason Purdue University, Indianapolis; Chiron Corporation, Emeryville MDS Pharma Services, New Orleans Palm Beach Atlantic University, West Palm BeachSearch for more papers by this authorAmerican Society for Clinical Pharmacology and Therapeutics Task Force on Dietary Supplements, Corresponding Author American Society for Clinical Pharmacology and Therapeutics Task Force on Dietary Supplements Michele Boisse, American Society for Clinical Pharmacology and Therapeutics, 528 N. Washington St, Alexandria, VA 22314. E-mail: [email protected]Search for more papers by this author First published: 07 March 2005 https://doi.org/10.1016/j.clpt.2005.01.017Citations: 10 The opinions, findings, conclusions, or recommendations put forth in this position paper are those of the authors and do not necessarily reflect the views of the organizations with which they are employed or engaged. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Dietary Supplement Health and Education Act (DSHEA), Public Law 103–417, 1994. Google Scholar 2 National Research Council. (2005). Dietary supplements: a framework for evaluating safety. Available from: URL: http://www.nap.edu/books/0309091101/html/. Accessed Jan 20, 2005. Google Scholar 3Balluz, L. S., Kieszak, S. M., Philen, R. M. and Mulinare, J. (2000). Vitamin and mineral supplement use in the United States: results from the Third National Health and Nutrition Examination Survey. Arch Fam Med. 9: 258–262. 10.1001/archfami.9.3.258 CASPubMedWeb of Science®Google Scholar 4Slesinski, M. J., Subar, A. F. and Kahle, L. L. (1995). Trends in use of vitamin and mineral supplements in the United States: the 1987 and 1992 National Health Interview Surveys. J Am Diet Assoc. 95: 921–923. 10.1016/S0002-8223(95)00255-3 PubMedWeb of Science®Google Scholar 5Blendon, R. J., Earaches, C. M., Benson, J. M., Brodie, M. and Altman, D. E. (2001). Americans' views on the use and regulation of dietary supplements. Arch Intern Med. 161: 805–810. 10.1001/archinte.161.6.805 CASPubMedWeb of Science®Google Scholar 6De Smet, P. A. G. M. (2004). Health risks of herbal remedies: an update. Clin Pharmacol Ther. 76: 1–17. 10.1016/j.clpt.2004.03.005 PubMedWeb of Science®Google Scholar 7Stein, C. M. (2002). Are herbal products dietary supplements or drugs? An important question for public safety. Clin Pharmacol Ther. 71: 411–413. 10.1067/mcp.2002.125975 PubMedWeb of Science®Google Scholar 8Wooltorton, E. and Sibbald, B. (2002). Ephedra/ephedrine: cardiovascular and CNS effects. CMAJ. 166: 633. PubMedWeb of Science®Google Scholar 9Haller, C. A. and Benowitz, N. L. (2000). Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 343: 1833–1838. 10.1056/NEJM200012213432502 CASPubMedWeb of Science®Google Scholar 10Hertzman, P. A., Falk, H., Kilbourne, E. M., Page, S. and Shulman, L. E. (1991). The eosinophilia-myalgia syndrome: the Los Alamos Conference. J Rheumatol. 18: 867–873. CASPubMedWeb of Science®Google Scholar 11 Center for Food Safety and Applied Nutrition, Office of Nutritional Products, Labeling, and Dietary Supplements, US Food and Drug Administration. Information paper on L-tryptophan and 5-hydroxy-L-tryptophan. February 2001. Available from: URL: http://www.cfsan.fda.gov/~dms/ds-tryp1.html. Accessed Jan 20, 2005. Google Scholar 12Wooltorton, E. (2002). Herbal kava: reports of liver toxicity. CMAJ. 166: 777. PubMedWeb of Science®Google Scholar 13Russmann, S., Lauterburg, B. H. and Helbling, A. (2001). Kava hepatotoxicity. Ann Intern Med. 135: 68–69. 10.7326/0003-4819-135-1-200107030-00036 CASPubMedWeb of Science®Google Scholar 14Congressional Record, Proceedings and debates of the 108th Congress, second session [Senate—June 21]. (2004) 86: S7077–S7086. Google Scholar 15 69 Federal Register 64957 (2004) [Docket No. 2004N-0458]. Dietary supplements: strategy for further implementation and enforcement of the Dietary Supplement Health and Education Act of 1994; availability. US Food and Drug Administration. Notice. Nov 9, 2004. Google Scholar 16 69 Federal Register 64962 (2004) [Docket No. 2004D-0466]. Draft guidance for industry: substantiation for dietary supplement claims made under Section 403(r)(6) of the Federal Food, Drug, and Cosmetic Act; availability. Food and Drug Administration. Notice. Nov 9, 2004. Google Scholar 17 Office of the Inspector General. Adverse event reporting for dietary supplements: an inadequate safety valve. OEI-01–00–00180. Boston: Office of the Inspector General, Department of Health and Human Services; 2001. Google Scholar 18Litovitz, T. L., Klein-Schwartz, W., White, S., Cobaugh, D. J., Youniss, J. and Drab, A. et al. (2000). 1999 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 18: 517–574. 10.1053/ajem.2000.9261 CASPubMedWeb of Science®Google Scholar 19 MedWatch: The FDA safety information and adverse event reporting program. Food and Drug Administration (US). Available from: URL: http://www.fda.gov/medwatch/. Accessed Nov 12, 2004. Google Scholar 20 US Pharmacopeia. Dietary supplements. Available from: URL: http://www.usp.org/dietarysupplements/. Accessed Nov 12, 2004. Google Scholar 21Marcus, D. M. and Grollman, A. P. (2002). Botanical medicines—the need for new regulations. N Engl J Med. 347: 2073–2076. 10.1056/NEJMsb022858 PubMedWeb of Science®Google Scholar 22 68 Federal Register 12158 (2003) (codified at 21 CFR Parts 111 and 112). Current good manufacturing practice in manufacturing, packing, or holding dietary ingredients and dietary supplements. US Food and Drug Administration. Proposed rule. Google Scholar 23 Office of the Inspector General. (2003) Dietary supplements labels: an assessment. OEI-01–01–00121. Boston: Office of the Inspector General, Department of Health and Human Services. Google Scholar 24 Report of the Commission on Dietary Supplement Labels. President's Commission on Dietary Supplement Labels. Nesheim MC, Chair. 1997 Nov. Google Scholar 25Moorman, C. H. (2004). Challenges of OTC labeling. Am Pharm Outsourcing. 5: 8–15. Google Scholar 26 Office of the Inspector General. (2003) Dietary supplements labels: key elements. OEI-01–01–00120. Boston: Office of the Inspector General, Department of Health and Human Services. Google Scholar 27 Consumers Union. Press release; 9 of 10 consumers want dietary supplements to be proven safe before put on store shelves. (June 7, 2004). Available from: URL: http://www.consumersunion.org/pub/core_product_safety/001171.html. Accessed Jan 20, 2005. Google Scholar 28Mackowiak, E. D. (2003). Natural product education. Am J Pharm Ed. 67: 15–17. Web of Science®Google Scholar 29Shields, K. M., McQueen, C. E. and Bryant, P. J. (2003). Natural product education in schools of pharmacy in the United States. Am J Pharm Ed. 67: 43–48. Web of Science®Google Scholar 30Wetzel, M. S., Eisenberg, D. M. and Kaptchuk, T. J. (1998). Courses involving complementary and alternative medicine at US medical schools. JAMA. 280: 784–787. 10.1001/jama.280.9.784 CASPubMedWeb of Science®Google Scholar 31Sergeant, M. J. (1999). Medical school courses in alternative medicine [letter]. JAMA. 281: 609–610. 10.1001/jama.281.7.609 CASPubMedWeb of Science®Google Scholar 32Park, C. M. (2002). Diversity, the individual, and proof of efficacy: complementary and alternative medicine in medical education. Am J Public Health. 92: 1568–1572. 10.2105/AJPH.92.10.1568 PubMedWeb of Science®Google Scholar 33Wetzel, M. S., Kaptchuk, T. J., Haramati, A. and Eisenberg, D. M. (2003). Complementary and alternative medical therapies: implications for medical education. Ann Intern Med. 138: 191–196. 10.7326/0003-4819-138-3-200302040-00011 PubMedWeb of Science®Google Scholar 34Brotherton, S. E., Rockey, P. H. and Etzel, S. I. (2004). US graduate medical education, 2003–2004. JAMA. 292: 1032–1037. 10.1001/jama.292.9.1032 CASPubMedWeb of Science®Google Scholar 35 DailyMed initiative enhancing patient safety through accessible medication information. Available from: URL: http://www.fda.gov/cder/regulatory/ersr/2003_02_13_dailymed/. Accessed Nov 12, 2004. Google Scholar 36 International Bibliographic Information on Dietary Supplements (IBIDS) database. Available from: URL: http://dietary-supplements.info.nih.gov/Health_Information/IBIDS.aspx. Accessed November 12, 2004. Google Scholar 37Landers S. J.. (Sept 6, 2004). Alphabet overload: which dietary supplements are effective? American Medical News online. Available from: URL: http://www.ama-assn.org/amednews/2004/09/06/hlsa0906.htm. Accessed Nov 12, 2004. Google Scholar 38ConsumerReports.org Web site. (May 2004) Dangerous supplements: still at large. Available from: URL: http://www.consumerreports.org/main/content/display_report.jsp?FOLDER%3C%3Efolder_id=419337&ASSORTMENT%3C%3East_id=333141&bmUID=1106339029120#. Accessed Jan 12, 2005. Google Scholar 39 Consumers Union. Consumers Union dietary supplements survey. (June 4, 2004). Available from: URL: http://www.consumersunion.org/pub/Supplements-press%20version.pdf Accessed Nov 12, 2004. Google Scholar 40Degan, F. H. (2003). Federal regulation of dietary supplements: eight years after DSHEA, where are we?. J Am Nutraceutical Assoc. 6: 20–24. Google Scholar 41O'Hara, M., Kiefer, D., Farrall, K. and Kemper, K. (1998). A review of 12 commonly used medicinal herbs. Arch Fam Med. 7: 523–536. 10.1001/archfami.7.6.523 CASPubMedWeb of Science®Google Scholar Citing Literature Volume77, Issue3March 2005Pages 113-122 ReferencesRelatedInformation
Referência(s)